Hundreds of children from Gaza to be brought to UK for urgent medical treatment
Under the scheme, reportedly set to be announced within weeks, more injured and sick children will be treated by specialists in the NHS "where that is the best option for their care".
It has been suggested that up to 300 children could arrive in the UK from Gaza.
A parent or guardian will accompany each child, as well as siblings if necessary, and the Home Office will carry out biometric and security checks before travel, the Sunday Times has reported.
It is understood this will happen "in parallel" with an initiative by Project Pure Hope, a group set up to bring sick and injured Gazan children to the UK privately for treatment.
15:52
A government spokesperson said: "We are taking forward plans to evacuate more children from Gaza who require urgent medical care, including bringing them to the UK for specialist treatment where that is the best option for their care."
More than 50,000 children are estimated to have been killed or injured in Gaza since October 2023, according to Unicef.
So far, three children have arrived in the UK for medical treatment with the help of the charity Project Pure Hope.
Around 5,000 have been evacuated in total, with the majority going to Egypt and Gulf countries.
Sir Keir Starmer said last week that the UK was "urgently accelerating" efforts to bring children over for treatment.
The government has also pledged another £1m to help the World Health Organisation in Egypt provide medical support to evacuated Gazans.
The prime minister told the Mirror: "I know the British people are sickened by what is happening.
"The images of starvation and desperation in Gaza are utterly horrifying. We are urgently accelerating efforts to evacuate children from Gaza who need critical medical assistance - bringing more Palestinian children to the UK for specialist medical treatment."
Around 100 MPs have signed a letter urging the government to fast track the scheme.
Labour MP Stella Creasy, who co-ordinated the letter, said: "The commitment we all share to help these children remains absolute and urgent - with every day, more are harmed or die, making the need to overcome any barriers to increasing the support we give them imperative.
"We stand ready to support whatever it takes to make this happen and ask for your urgent response."
Meanwhile, Project Pure Hope has been campaigning for months to create a scheme which would allow for the evacuation of 30 to 50 children.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
an hour ago
- Daily Mirror
'My seatbelt saved my life - but I wasn't even involved in a car crash'
Natalie Deakin, from Nuneaton, Warwickshire, says she is "really grateful" for her car's seatbelt - because she believes it helped her spot a key symptom of her stage-two Hodgkin Lymphoma A mum says her car seatbelt for saving her life - as the "'irritating" strap led her to discover a cancerous lump hidden in her neck. When the device began causing Natalie Deakin discomfort on her drive home from the weekly shop, she tried to readjust its position. However, the 34-year-old woman felt a hard lump on the right side of her neck. And so the mum of two immediately booked an appointment with her GP who ordered a series of tests on the golf ball-sized mass. A CT scan and biopsy then revealed Natalie had Hodgkin Lymphoma - an uncommon cancer which develops in the lymphatic system. Natalie, who is a hairdresser, said: "Never in a million years did I think I'd be saying I had cancer at 34... I feel like the seat belt has probably factored in saving my life, which is strange. I'm really grateful for it. Things could've been very different for me. "People should be very vigilant over our bodies. Check yourself all the time. If you notice any sort of change and think that's not normal, get it checked out." Natalie had experienced no symptoms or changes in her health in the lead up to her cancer diagnosis, other than discovering the lump in her neck in her car. The mum, who is due to begin chemotherapy treatment, continued: "Life was normal. I had no symptoms, nothing. There were no changes in my body. I felt very fit and healthy. I didn't have any other symptoms. If I hadn't found the lump, I would've just carried on with life as normal. "I was on my way back from the supermarket after doing the weekly shop and I kept thinking the seatbelt was really irritating my neck. "I moved it away a few times and repositioned it but thought what is it doing? Then all of a sudden, I moved it away from me and touched my neck and felt this big mass in my neck. I just thought what on earth is that? I just remember the fear, anxiety and sickness that went through me." Cancer Research UK provide details on lymphoma The salon owner, of Nuneaton, Warwickshire, has stage-two Hodgkin Lymphoma. Around 2,100 people are diagnosed with Hodgkin lymphoma in the UK each year, according to the NHS. Typically, swelling in the neck, armpit or groin is an early sign of the cancer. This is caused by an excess of affected lymphocytes (white blood cells) collecting in a lymph node. But in Natalie's case, the lump was her first sign - and she is now imploring others to check their own bodies for any abnormal changes. She added: "I was thinking about my own funeral. It was awful to think that - I didn't think I'd be thinking about that until I was in my 80s. "We had so many wonderful things booked for this year but none of them can go ahead. My life has come to a standstill. How can you live your life normally, go shopping, find a lump and your whole life falls apart in that one second."
South Wales Argus
2 hours ago
- South Wales Argus
Patients to be fast-tracked on to new head and neck cancer vaccine trial
The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'
Leader Live
2 hours ago
- Leader Live
Patients to be fast-tracked on to new head and neck cancer vaccine trial
The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'
